Studies on antimicrobial peptide-loaded nanomaterial for root caries restorations to inhibit periodontitis related pathogens in periodontitis care

References

• Acchione, M., et al., 2012. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. MAbs, 4 (3), 362–372.
   PubMed Web of Science ®Google Scholar
• Agnihotri, S.A., Mallikarjuna, N.N., and Aminabhavi, T.M., 2004. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. Journal of controlled release, 100 (1), 5–28.
   PubMed Web of Science ®Google Scholar
• Anand, M., et al., 2014. Extraction and characterization of chitosan from marine crab and squilla collected from the Gulf of Mannar Region, South India. Journal of chitin and chitosan science, 2 (4), 280–287.
   Google Scholar
• Armitage, G.C. and Robertson, P.B., 2009. The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. The journal of the American Dental Association, 140 (1), 36s–43s.
   PubMed Web of Science ®Google Scholar
• Ashby, M.T., et al., 2009. Influence of a model human defensive peroxidase system on oral streptococcal antagonism. Microbiology, 155 (11), 3691–3700.
   PubMed Web of Science ®Google Scholar
• Bourgeois, D., et al., 2019. Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease-is there cause for consideration? Microorganisms, 7 (10), 424.
   PubMed Web of Science ®Google Scholar
• Bui, F.Q., et al., 2019. Association between periodontal pathogens and systemic disease. Biomedical journal, 42 (1), 27–35.
   PubMed Web of Science ®Google Scholar
• Calvo, P., et al., 1997. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharmaceutical research, 14 (10), 1431–1436.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2014. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Molecular pharmaceutics, 11 (7), 2213–2223.
   PubMed Web of Science ®Google Scholar
• Dhawan, S. and Singla, A.K., 2003. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation. Biotechnic & histochemistry, 78 (5), 243–254.
   PubMed Web of Science ®Google Scholar
• Frencken, J.E., et al., 2017. Global epidemiology of dental caries and severe periodontitis-a comprehensive review. Journal of clinical periodontology, 44 (18), S94–S105.
   PubMed Web of Science ®Google Scholar
• Gan, Q., et al., 2005. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids and surfaces. B, biointerfaces, 44 (2–3), 65–73.
   PubMed Web of Science ®Google Scholar
• Gan, Q. and Wang, T., 2007. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids and surfaces. B, biointerfaces, 59 (1), 24–34.
   PubMed Web of Science ®Google Scholar
• Hancock, R.E.W. and Lehrer, R., 1998. Cationic peptides: a new source of antibiotics. Trends in biotechnology, 16 (2), 82–88.
   PubMed Web of Science ®Google Scholar
• Haryadi, B.M., et al., 2019. Nonspherical nanoparticle shape stability is affected by complex manufacturing aspects: its implications for drug delivery and targeting. Advanced healthcare materials, 8 (18), e1900352.
   PubMed Web of Science ®Google Scholar
• Hillaireau, H. and Couvreur, P., 2009. Nanocarriers’ entry into the cell: relevance to drug delivery. Cellular and molecular life sciences, 66 (17), 2873–2896.
   PubMed Web of Science ®Google Scholar
• Hoiby, N., et al., 2010. Antibiotic resistance of bacterial biofilms. International journal of antimicrobial agents, 35 (4), 322–332.
   PubMed Web of Science ®Google Scholar
• Holtfreter, B., et al., 2010. Prevalence of periodontal disease and treatment demands based on a German dental survey (DMS IV). Journal of clinical periodontology, 37 (3), 211–219.
   PubMed Web of Science ®Google Scholar
• Hugoson, A., Sjödin, B., and Norderyd, O., 2008. Trends over 30 years, 1973-2003, in the prevalence and severity of periodontal disease. Journal of clinical periodontology, 35 (5), 405–414.
   PubMed Web of Science ®Google Scholar
• Hussain, M., Stover, C.M., and Dupont, A.P., 2015. P. gingivalis in periodontal disease and atherosclerosis - scenes of action for antimicrobial peptides and complement. Frontiers in immunology, 6, 45.
   PubMed Web of Science ®Google Scholar
• Iniyan, A.M., et al., 2017. In vivo safety evaluation of antibacterial silver chloride nanoparticles from Streptomyces exfoliatus ICN25 in zebrafish embryos. Microbial pathogenesis, 112, 76–82.
   PubMed Web of Science ®Google Scholar
• Intrado., 2016. Pacgen announces progress on PAC-113 license [online]. Vancouver, Canada, Pacgen Life Science Corporation. Available from: http://www.marketwired.com/press-release/pacgen-announces-progress-on-pac-113-license-2151000.htm [Accessed 13 Nov 2016].
   Google Scholar
• Kalaiarasi, S., et al., 2016. Development of biocompatible nanogel for sustained drug release by overcoming the blood brain barrier in zebrafish model. Journal of applied biomedicine, 14 (2), 157–169.
   Web of Science ®Google Scholar
• Koo, H., et al., 2017. Targeting microbial biofilms: current and prospective therapeutic strategies. Nature reviews. Microbiology, 15 (12), 740–755.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2004. Identification of early microbial colonizers in human dental biofilm. Journal of applied microbiology, 97 (6), 1311–1318.
   PubMed Web of Science ®Google Scholar
• Li, W.J., et al., 2013. Current drug research on PEGylation with small molecular agents. Progress in polymer science, 38 (3–4), 421–444.
   Web of Science ®Google Scholar
• Lin, I.J., et al., 1999. Solution structure and RNA binding activity of the N-terminal leucine repeat region of hepatitis delta antigen. Proteins: structure, function, and genetics, 37 (1), 121–129.
   PubMed Web of Science ®Google Scholar
• Liu, Q., et al., 2018. Lactose-modified chitosan gold(III)-PEGylated complex-bioconjugates: from synthesis to interaction with targeted galectin-1 protein. Bioconjugate chemistry, 29 (10), 3352–3361.
   PubMed Web of Science ®Google Scholar
• Liu, X.-X., et al., 2019. Analysis of salivary microbiome in patients with Alzheimer’s disease. Journal of Alzheimer’s disease, 72 (2), 633–640.
   PubMed Web of Science ®Google Scholar
• Mättö, J., et al., 2004. Genetic heterogeneity and functional properties of intestinal bifdobacteria. Journal of applied microbiology, 97 (3), 459–470.
   PubMed Web of Science ®Google Scholar
• Menghini, G., et al., 2008. Dental health of adults in the Zurich Canton. Schweiz. Monatsschr. Zahnmed, 112 (7), 708–717.
   Google Scholar
• Mombelli, A., 2018. Microbial colonization of the periodontal pocket and its significance for periodontal therapy. Periodontology 2000, 76 (1), 85–96.
   PubMed Web of Science ®Google Scholar
• Narayanan, D., et al., 2013. In vitro and in vivo evaluation of osteoporosis therapeutic peptide PTH 1-34 loaded pegylated chitosan nanoparticles. Molecular pharmaceutics, 10 (11), 4159–4167.
   PubMed Web of Science ®Google Scholar
• Nazir, M.A., 2017. Prevalence of periodontal disease, its association with systemic diseases and prevention. International journal of health sciences, 11 (2), 72–80.
   PubMedGoogle Scholar
• Pem, B., et al., 2019. Beilstein toxicity and safety study of silver and gold nanoparticles functionalized with cysteine and glutathione. Beilstein journal of nanotechnology, 10, 1802–1817.
   PubMed Web of Science ®Google Scholar
• Pletzer, D. and Hancock, R.E.W., 2016. Antibiofilm peptides: potential as broad-spectrum agents. Journal of bacteriology, 198 (19), 2572–2578.
   PubMed Web of Science ®Google Scholar
• Rams, T.E., Degener, J.E., and Van, Winkelhoff, A.J., 2014. Antibiotic resistance in human chronic periodontitis microbiota. Journal of periodontology, 85 (1), 160–169.
   PubMed Web of Science ®Google Scholar
• Robert Koch-Institut., 2009. Gesundheitsberichterstattung des Bundes, Heft 47 Mundgesundheit, Robert Koch-Institut in Zusammenarbeit mit dem Statistischen Bundesamt [online]. Berlin, Germany, Robert Koch-Institut. Available from: http://www.bzaek.de/fileadmin/PDFs/Infos/RKIThemenheft47Mundgesundheit.pdf [Accessed on 27 October 2015].
   Google Scholar
• Rogers, JG., 2011. Evidence-based oral health promotion resource [online]. Melbourne, Australia, Prevention and Population Health Branch, Government of Victoria, Department of Health. Available from: http://docs.health.vic.gov.au/docs/doc/ 1A32DFB77FEFBE9CCA25789900125529/$FILE/Final%0Oral%20Health%20Resource%20May%202011%20web% 20version.pdf [Accessed 27 October 2015].
   Google Scholar
• Rudilla, H., et al., 2016. Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems. Molecules, 21 (9), 1223.
   Web of Science ®Google Scholar
• Statistics and Information Department, Ministry of Health, Labour and Welfare, Japan., 2008. Estimates of national medical care expenditure [online]. Tokyo, Japan, Ministry of Health, Labour and Welfare. Available from: http://www.mhlw.go.jp/english/database/db-hss/dl/pbs_2008.pdf [Accessed on 27 October 2015].
   Google Scholar
• Suzuki, N., Yoneda, M., and Hirofuji, T., 2013. Mixed red-complex bacterial infection in periodontitis. International journal of dentistry, 2013, 587279.
   PubMedGoogle Scholar
• Teixeira, M., et al., 2019. Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line. Pharmaceutical development and technology, 24 (9), 1104–1114.
   PubMed Web of Science ®Google Scholar
• Wang, C.W., et al., 2009. Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens. FEMS yeast research, 9 (6), 967–970.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2018. The effects of antimicrobial peptide Nal-P-113 on inhibiting periodontal pathogens and improving periodontal status. BioMed research international, 2018, 1805793–1805799.
   PubMed Web of Science ®Google Scholar
• Wang, H.Y., et al., 2015. Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta biomaterialia, 25, 150–161.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2016. Novel bioactive nanocomposite for Class-V restorations to inhibit periodontitis-related pathogens. Dental materials, 32 (12), 351–361.
   Web of Science ®Google Scholar
• Woeppel, K.M., et al., 2019. Nanoparticle doped PEDOT for enhanced electrode coatings and drug delivery. Advanced healthcare materials, 8 (21), 1900622.
   Web of Science ®Google Scholar
• Yu, H.Y., et al., 2011. Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrobial agents and chemotherapy, 55 (10), 4918–4921.
   PubMed Web of Science ®Google Scholar